Novel mutations associated with combined pituitary hormone deficiency

Journal of Molecular Endocrinology

Volumn 46, Issue 3, 2011, Pages

  Romero, Christopher J ^a   Pine Twaddell, Elyse ^a   Radovick, Sally ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PROPHET OF PIT 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR LHX4; TRANSCRIPTION FACTOR OTX2; UNCLASSIFIED DRUG;

GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HYPOPITUITARISM; NONHUMAN; PATHOPHYSIOLOGY; POU1F1 GENE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHILD; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; HYPOPITUITARISM; INFANT; MUTATION; PITUITARY GLAND; PITUITARY HORMONES; TRANSCRIPTION FACTORS;

EID: 79959513055     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-10-0133     Document Type: Review

References (72)

1. Abrao MG, Leite MV, Carvalho LR, Billerbeck AE, Nishi MY, Barbosa AS, Martin RM, Arnhold IJ & Mendonca BB 2006 Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clinical Endocrinology 65 294-300. (doi:10.1111/j.1365-2265.2006.02592.x)
2. Acampora D, Gulisano M & Simeone A 2000 Genetic and molecular roles of otx homeodomain proteins in head development. Gene 246 23-35. (doi:10.1016/S0378-1119(00)00070-6)
3. Agarwal G, Bhatia V, Cook S & Thomas PQ 2000 Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. Journal of Clinical Endocrinology and Metabolism 85 4556-4561. (doi:10.1210/jc.85.12. 4556)
4. Andoniadou CL, Signore M, Sajedi E, Gaston-Massuet C, Kelberman D, Burns AJ, Itasaki N, Dattani M & Martinez-Barbera JP 2007 Lack of the murine homeobox gene Hesx1 leads to a posterior transformation of the anterior forebrain. Development 134 1499-1508. (doi:10.1242/dev.02829)
5. Bhangoo AP, Hunter CS, Savage JJ, Anhalt H, Pavlakis S, Walvoord EC, Ten S & Rhodes SJ 2006 Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. Journal of Clinical Endocrinology and Metabolism 91 747-753. (doi:10. 1210/jc.2005-2360)
6. Brickman JM, Clements M, Tyrell R, McNay D, Woods K, Warner J, Stewart A, Beddington RS & Dattani M 2001 Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 128 5189-5199.
7. Carlomagno Y, Salerno M, Vivenza D, Capalbo D, Godi M, Mellone S, Tiradani L, Corneli G, Momigliano-Richiardi P, Bona G et al. 2009 A novel recessive splicing mutation in the POU1F1 gene causing combined pituitary hormone deficiency. Journal of Endocrinological Investigation 32 653-658.
8. Carvalho LR, Woods KS, Mendonca BB, Marcal N, Zamparini AL, Stifani S, Brickman JM, Arnhold IJ & Dattani MT 2003 A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. Journal of Clinical Investigation 112 1192-1201. (doi:10.1172/ JCI18589)
9. Carvalho LR, Brinkmeier ML, Castinetti F, Ellsworth BS & Camper SA 2010 Corepressors TLE1 andTLE3 interact withHESX1and PROP1. Molecular Endocrinology 24 754-765. (doi:10.1210/me.2008-0359)
10. Castinetti F, Saveanu A, Reynaud R, Quentien MH, Buffin A, Brauner R, Kaffel N, Albarel F, Guedj AM, El Kholy M et al. 2008 A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 93 2790-2799. (doi:10.1210/jc.2007-2389)
11. Cohen LE, Radovick S & Wondisford FE 1999a Transcription factors and hypopituitarism. Trends in Endocrinology & Metabolism 10 326-332. (doi:10.1016/S1043-2760(99)00180-0)
12. Cohen LE, Zanger K, Brue T, Wondisford FE & Radovick S 1999b Defective retinoic acid regulation of the pit-1 gene enhancer: a novel mechanism of combined pituitary hormone deficiency. Molecular Endocrinology 13 476-484. (doi:10.1210/me.13.3.476)
13. Coya R, Vela A, Perez de Nanclares G, Rica I, Castano L, Busturia MA, Martul P & GEDPIT group 2007 Panhypopituitarism: genetic versus acquired etiological factors. Journal of Pediatric Endocrinology & Metabolism 20 27-36.
14. Dasen JS & Rosenfeld MG 2001 Signaling and transcriptional mechanisms in pituitary development. Annual Review of Neuroscience 24 327-355. (doi:10.1146/annurev.neuro.24.1.327)
15. Dateki S, Fukami M, Sato N, Muroya K, Adachi M & Ogata T 2008 OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. Journal of Clinical Endocrinology and Metabolism 93 3697-3702. (doi:10.1210/jc.2008-0720)
16. Dateki S, Kosaka K, Hasegawa K, Tanaka H, Azuma N, Yokoya S, Muroya K, Adachi M, Tajima T, Motomura K et al. 2009 Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. Journal of Clinical Endocrinology and Metabolism 95 756-764. (doi:10.1210/jc.2009-1334)
17. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC et al. 1998 Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genetics 19 125-133. (doi:10.1038/477)
18. Diaczok D, Romero C, Zunich J, Marshall I & Radovick S 2008 A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism 93 4351-4359. (doi:10.1210/jc.2008-1189)
19. Duquesnoy P, Roy A, Dastot F, Ghali I, Teinturier C, Netchine I, Cacheux V, Hafez M, Salah N, Chaussain JL et al. 1998 Human prop-1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency. FEBS Letters 437 216-220. (doi:10.1016/S0014-5793(98)01234-4)
20. Gaston-Massuet C, Andoniadou CL, Signore M, Sajedi E, Bird S, Turner JM &Martinez-Barbera JP 2008 Genetic interaction between the homeobox transcription factors HESX1 and SIX3 is required for normal pituitary development. Developmental Biology 324 322-333. (doi:10.1016/j.ydbio.2008.08.008)
21. Henderson RH, Williamson KA, Kennedy JS, Webster AR, Holder GE, Robson AG, Fitz Patrick DR, van Heyningen V & Moore AT 2009 A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction. Molecular Vision 15 2442-2447.
22. Hermesz E, Mackem S & Mahon KA 1996 Rpx: a novel anteriorrestricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 122 41-52.
23. Kato Y, Kimoto F, Susa T, Nakayama M, Ishikawa A & Kato T 2010 Pituitary homeodomain transcription factors HESX1 and PROP1 form a heterodimer on the inverted TAAT motif. Molecular and Cellular Endocrinology 315 168-173. (doi:10.1016/j.mce.2009.10.006)
24. Kelberman D & Dattani MT 2006 The role of transcription factors implicated in anterior pituitary development in the aetiology of congenital hypopituitarism. Annals of Medicine 38 560-577. (doi:10.1080/07853890600994963)
25. Kelberman D & Dattani MT 2007 Hypopituitarism oddities: congenital causes. Hormone Research 68 (Supplement 5) 138-144. (doi:10.1159/ 000110610)
26. Kelberman D, Rizzoti K, Avilion A, Bitner-Glindzicz M, Cianfarani S, Collins J, Chong WK, Kirk JM, Achermann JC, Ross R et al. 2006 Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. Journal of Clinical Investigation 116 2442-2455. (doi:10.1172/ JCI28658)
27. Kelberman D, Turton J, Woods K, Mehta A, Al-Khawari M, Greening J, Swift P, Otonkoski T, Rhodes S & Dattani M 2008a Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency. Clinical Endocrinology 70 96-103. (doi:10.1111/j.1365-2265.2008.03326.x)
28. Kelberman D, de Castro SC, Huang S, Crolla JA, Palmer R, Gregory JW, Taylor D, Cavallo L, Faienza MF, Fischetto R et al. 2008b SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development. Journal of Clinical Endocrinology and Metabolism 93 1865-1873. (doi:10.1210/jc.2007-2337)
29. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC & Dattani MT 2009 Genetic regulation of pituitary gland development in human and mouse. Endocrine Reviews 30 790-829. (doi:10.1210/er.2009-0008)
30. Kristrom B, Zdunek AM, Rydh A, Jonsson H, Sehlin P & Escher SA 2009 A novel mutation in the LHX3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations. Journal of Clinical Endocrinology and Metabolism 94 1154-1161. (doi:10.1210/jc.2008-0325)
31. Kurokawa D, Kiyonari H, Nakayama R, Kimura-Yoshida C, Matsuo I & Aizawa S 2004 Regulation of Otx2 expression and its functions in mouse forebrain andmidbrain. Development 131 3319-3331. (doi:10. 1242/dev.01220)
32. Lemos MC, Gomes L, Bastos M, Leite V, Limbert E, Carvalho D, Bacelar C, Monteiro M, Fonseca F, Agapito A et al. 2006 PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency. Clinical Endocrinology 65 479-485. (doi:10.1111/j.1365-2265.2006.02617.x)
33. Liu Y, Fan M, Yu S, Zhou Y, Wang J, Yuan J & Qiang B 2002 cDNA cloning, chromosomal localization and expression pattern analysis of human LIM-homeobox gene LHX4. Brain Research 928 147-155. (doi:10.1016/S0006-8993(01)03243-7)
34. Machinis K & Amselem S 2005 Functional relationship between LHX4 and POU1F1 in light of the LHX4 mutation identified in patients with pituitary defects. Journal of Clinical Endocrinology and Metabolism 90 5456-5462. (doi:10.1210/jc.2004-2332)
35. Machinis K, Pantel J, Netchine I, Leger J, Camand OJ, Sobrier ML, Dastot-Le Moal F, Duquesnoy P, Abitbol M, Czernichow P et al. 2001 Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. American Journal of Human Genetics 69 961-968. (doi:10.1086/323764)
36. McGillivray SM, Bailey JS, Ramezani R, Kirkwood BJ & Mellon PL 2005 Mouse GnRH receptor gene expression is mediated by the LHX3 homeodomain protein. Endocrinology 146 2180-2185. (doi:10.1210/ en.2004-1566)
37. McNay DE, Turton JP, Kelberman D, Woods KS, Brauner R, Papadimitriou A, Keller E, Keller A, Haufs N, Krude H et al. 2007 HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. Journal of Clinical Endocrinology and Metabolism 92 691-697. (doi:10.1210/jc.2006-1609)
38. Miyata I, Vallette-Kasic S, Saveanu A, Takeuchi M, Yoshikawa H, Tajima A, Tojo K, Reynaud R, Gueydan M, Enjalbert A et al. 2006 Identification and functional analysis of the novel S179R POU1F1 mutation associated with combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism 91 4981-4987. (doi:10.1210/jc.2005-2289)
39. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R et al. 2006 Homeodomainmediated beta-catenin-dependent switching events dictate celllineage determination. Cell 125 593-605. (doi:10.1016/j.cell.2006. 02.046)
40. Pfaeffle RW, Savage JJ, Hunter CS, Palme C, Ahlmann M, Kumar P, Bellone J, Schoenau E, Korsch E, Bramswig JH et al. 2007 Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. Journal of Clinical Endocrinology and Metabolism 92 1909-1919. (doi:10.1210/jc.2006-2177)
41. Pfaeffle RW, Hunter CS, Savage JJ, Duran-Prado M, Mullen RD, Neeb ZP, Eiholzer U, Hesse V, Haddad NG, Stobbe HM et al. 2008 Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies. Journal of Clinical Endocrinology and Metabolism 93 1062-1071. (doi:10.1210/jc.2007-1525)
42. Qi Y, Ranish JA, Zhu X, Krones A, Zhang J, Aebersold R, Rose DW, Rosenfeld MG & Carriere C 2008 Atbf1 is required for the Pit1 gene early activation. PNAS 105 2481-2486. (doi:10.1073/pnas. 0712196105)
43. Rajab A, Kelberman D, de Castro SC, Biebermann H, Shaikh H, Pearce K, Hall CM, Shaikh G, Gerrelli D, Grueters A et al. 2008 Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Human Molecular Genetics 17 2150-2159. (doi:10.1093/hmg/ddn114)
44. Reynaud R, Saveanu A, Barlier A, Enjalbert A & Brue T 2004 Pituitary hormone deficiencies due to transcription factor gene alterations. Growth Hormone & IGF Research 14 442-448. (doi:10.1016/j.ghir. 2004.07.001)
45. Reynaud R, Gueydan M, Saveanu A, Vallette-Kasic S, Enjalbert A, Brue T & Barlier A 2006 Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. Journal of Clinical Endocrinology and Metabolism 91 3329-3336. (doi:10.1210/jc.2005-2173)
46. Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A & Muenke M 2003 Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. PNAS 100 13424-13429. (doi:10.1073/pnas.2235734100)
47. Rosenfeld MG 1991 POU-domain transcription factors: pou-er-ful developmental regulators. Genes and Development 5 897-907. (doi:10.1101/gad.5.6.897)
48. Sajedi E, Gaston-Massuet C, Andoniadou CL, Signore M, Hurd PJ, Dattani M & Martinez-Barbera JP 2008a DNMT1 interacts with the developmental transcriptional repressor HESX1. Biochimica et Biophysica Acta 1783 131-143. (doi:10.1016/j.bbamcr.2007.08.010)
49. Sajedi E, Gaston-Massuet C, Signore M, Andoniadou CL, Kelberman D, Castro S, Etchevers HC, Gerrelli D, Dattani MT & Martinez-Barbera JP 2008b Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism. Disease Models & Mechanisms 1 241-254. (doi:10.1242/dmm.000711)
50. Schilter KF, Schneider A, Bardakjian T, Soucy JF, Tyler RC, Reis LM & Semina EV 2010 OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clinical Genetics 79 158-168. (doi:10.1111/j.1399-0004.2010.01450.x)
51. Scully KM & Rosenfeld MG 2002 Pituitary development: regulatory codes in mammalian organogenesis. Science 295 2231-2235. (doi:10. 1126/science.1062736)
52. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA & Westphal H 1997 Multistep control of pituitary organogenesis. Science 278 1809-1812. (doi:10.1126/science.278.5344.1809)
53. Sloop KW, Meier BC, Bridwell JL, Parker GE, Schiller AM & Rhodes SJ 1999 Differential activation of pituitary hormone genes by human Lhx3 isoforms with distinct DNA binding properties. Molecular Endocrinology 13 2212-2225. (doi:10.1210/me.13.12.2212)
54. Sloop KW, Dwyer CJ & Rhodes SJ 2001 An isoform-specific inhibitory domain regulates the LHX3 LIM homeodomain factor holoprotein and the production of a functional alternate translation form. Journal of Biological Chemistry 276 36311-36319. (doi:10.1074/jbc. M103888200)
55. Snabboon T, Plengpanich W, Buranasupkajorn P, Khwanjaipanich R, Vasinanukorn P, Suwanwalaikorn S, Khovidhunkit W & Shotelersuk V 2008 A novel germline mutation, IVS4C1GOA, of the POU1F1 gene underlyingcombined pituitary hormone deficiency. Hormone Research 69 60-64. (doi:10.1159/000111797)
56. Sobrier ML, Maghnie M, Vie-Luton MP, Secco A, di Iorgi N, Lorini R & Amselem S 2006 Novel HESX1 mutations associated with a lifethreatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. Journal of Clinical Endocrinology and Metabolism 91 4528-4536. (doi:10.1210/jc.2006-0426)
57. Solomon NM, Ross SA, Forrest SM, Thomas PQ, Morgan T, Belsky JL, Hol FA, Karnes PS, Hopwood NJ, Myers SE et al. 2007 Array comparative genomic hybridisation analysis of boys with X-linked hypopituitarism identifies a 3.9 mb duplicated critical region at Xq27 containing SOX3. Journal of Medical Genetics 44 e75. (doi:10. 1136/jmg.2007.049049)
58. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP et al. 1996 Pituitary lineage determination by the prophet of pit-1 homeodomain factor defective in ames dwarfism. Nature 384 327-333. (doi:10.1038/ 384327a0)
59. Tajima T, Hattorri T, Nakajima T, Okuhara K, Sato K, Abe S, Nakae J & Fujieda K 2003 Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. Journal of Clinical Endocrinology and Metabolism 88 45-50. (doi:10.1210/jc.2002-020818)
60. Tajima T, Yorifuji T, Ishizu K & Fujieda K 2009a A novel mutation (V101A) of the LHX4 gene in a Japanese patient with combined pituitary hormone deficiency. Experimental and Clinical Endocrinology & Diabetes 118 405-409. (doi:10.1055/s-0029-1225612)
61. Tajima T, Ohtake A, Hoshino M, Amemiya S, Sasaki N, Ishizu K & Fujieda K 2009b OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. Journal of Clinical Endocrinology andMetabolism 94 314-319. (doi:10.1210/jc.2008-1219)
62. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y & Kohno H 1992 Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nature Genetics 1 56-58. (doi:10.1038/ng0492-56)
63. Thomas P & Beddington R 1996 Anterior primitive endoderm may be responsible for patterning the anterior neural plate in the mouse embryo. Current Biology 6 1487-1496. (doi:10.1016/S0960-9822(96)00753-1)
64. Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D et al. 2001 Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Human Molecular Genetics 10 39-45. (doi:10.1093/hmg/10.1.39)
65. Turton JP, Mehta A, Raza J, Woods KS, Tiulpakov A, Cassar J, Chong K, Thomas PQ, Eunice M, Ammini AC et al. 2005a Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clinical Endocrinology 63 10-18. (doi:10.1111/j.1365-2265.2005.02291.x)
66. Turton JP, Reynaud R, Mehta A, Torpiano J, Saveanu A, Woods KS, Tiulpakov A, Zdravkovic V, Hamilton J, Attard-Montalto S et al. 2005b Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism 90 4762-4770. (doi:10.1210/jc.2005-0570)
67. Ward RD, Davis SW, Cho M, Esposito C, Lyons RH, Cheng JF, Rubin EM, Rhodes SJ, Raetzman LT, Smith TP et al. 2007 Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene. Mammalian Genome 18 521-537. (doi:10.1007/ s00335-007-9008-6)
68. West BE, Parker GE, Savage JJ, Kiratipranon P, Toomey KS, Beach LR, Colvin SC, Sloop KW & Rhodes SJ 2004 Regulation of the folliclestimulating hormone beta gene by the LHX3 LIM-homeodomain transcription factor. Endocrinology 145 4866-4879. (doi:10.1210/en. 2004-0598)
69. Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, Palmer R, Wong J, Chong WK, Al-Zyoud M, El-Ali M et al. 2005 Over-and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. American Journal of Human Genetics 76 833-849. (doi:10. 1086/430134)
70. Xu L, Lavinsky RM, Dasen JS, Flynn SE, McInerney EM, Mullen TM, Heinzel T, Szeto D, Korzus E, Kurokawa R et al. 1998 Signal-specific co-activator domain requirements for pit-1 activation. Nature 395 301-306. (doi:10.1038/26270)
71. Zhu X, Zhang J, Tollkuhn J, Ohsawa R, Bresnick EH, Guillemot F, Kageyama R & Rosenfeld MG 2006 Sustained notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes and Development 20 2739-2753. (doi:10.1101/gad.1444706)
72. Zhu X, Wang J, Ju BG & Rosenfeld MG 2007 Signaling and epigenetic regulation of pituitary development. Current Opinion in Cell Biology 19 605-611. (doi:10.1016/j.ceb.2007.09.011)